Adverse Cardiovascular and Pulmonary Events Associated With Chimeric Antigen Receptor T-Cell Therapy. Goldman A, Maor E, Bomze D, Liu JE, et al. J Am Coll Cardiol 2021;78:1800-1813.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Goldman A, Maor E, Bomze D, Liu JE, et al. Adverse Cardiovascular and Pulmonary Events Associated With Chimeric Antigen Receptor T-Cell Therapy. J Am Coll Cardiol 2021;78:1800-1813.
PMID: 34711339